The RCA framework suggests that cancer cells are not primarily mutant cells β they are progenitor cells arrested in an undifferentiated state. This distinction is falsifiable, clinically supported, and opens a fundamentally different research direction.
Cancer cells share the phenotype of progenitor cells: proliferation, Warburg metabolism, immature structure. The difference is state, not mutation.
In Acute Promyelocytic Leukaemia, ATRA restores differentiation and achieves cure β demonstrating that internal differentiation control can be re-established.
Mina Bissell's ECM research shows cancer cells can normalise in a healthy tissue environment β external differentiation control can also be restored.
Repair and Capacity Adaptation (RCA) is a systems-level description of how tissue architecture governs cell fate. Cancer, in this view, is not a cell-autonomous disease β it is a failure of the regulatory architecture that controls differentiation.
RCA proposes two complementary regulatory layers: internal (differentiation signalling, as in APL/ATRA) and external (tissue microenvironment, as in Bissell's ECM experiments). Cancer may represent failure of both.
"Cancer behaves as a reversible systems disorder of differentiation control β consistent with a progenitor cell trapped in an undifferentiated state."
The RCA hypothesis is not proposed in isolation. It is consistent with, and provides a unifying framework for, three independent lines of existing evidence.
Progenitor cells naturally proliferate, display high metabolic activity (Warburg-like), and have an immature cellular structure. These are the same properties that define cancer cells. RCA suggests the difference is state, not irreversible mutation.
Acute Promyelocytic Leukaemia (APL) involves a differentiation arrest at the promyelocyte stage. All-Trans Retinoic Acid (ATRA) restores the differentiation programme, allowing cells to mature and achieving near-complete cure rates without targeting mutations directly.
Mina Bissell's laboratory demonstrated that cancer cells can normalise their behaviour when placed in a healthy extracellular matrix (ECM). Conversely, normal cells may acquire malignant properties in a disrupted ECM β without genetic changes.
APL and Bissell are not isolated findings β they are independent demonstrations of the same principle from different angles. Cancer can be reversed by restoring either internal control (APL/ATRA) or external control (ECM restoration). RCA provides the unifying systems framework above both TME and TOFT.
The RCA hypothesis makes a clear, testable prediction. If cancer cells are trapped progenitor cells, they should share a specific phenotypic profile β independent of mutation status.
Are cancer cells functionally equivalent to progenitor cells arrested in an undifferentiated state?
We are looking for laboratories willing to co-design the decisive validation experiment.
Join the ExperimentThe following experiments are designed to make RCA experimentally tractable. Each test addresses a specific prediction of the progenitor-arrest model.
Comprehensive phenotypic comparison of tissue-specific cancer cells and matched progenitor populations β transcriptome, proteome, ECM interaction, and differentiation responsiveness.
Systematic screening for tissue-specific differentiation inducers analogous to ATRA in APL β identifying agents that restore the internal differentiation programme in solid tumours.
Testing whether restoration of Reticular Lamina integrity in tumour microenvironments reduces cancer cell proliferation and promotes differentiation β replicating Bissell's framework in clinically relevant solid tumour models.
Investigating the mechanistic link between chronic infection, ECM degradation, and cancer initiation β testing whether pathogen-driven ECM disruption creates the permissive environment for progenitor arrest.
Primary disease focus β prostate cancer as model system for ECM-governed differentiation arrest.
Metabolic signatures of arrested progenitors β Warburg effect as phenotypic marker, not driver.
Neural progenitor arrest in gliomas β highest unmet need meets most tractable RCA model.
Epigenetic locks maintaining progenitor state β how differentiation arrest is encoded and reversed.
Intercellular signalling and gap junction disruption in ECM degradation cascade.
Complex systems modelling of tissue-level regulatory collapse β beyond the single-cell view.
The brain's control keyboard β the Psychobiological Interface (PBI) β represents a set of regulatory channels through which psychological and neuroendocrine states may influence tissue-level differentiation control in the RCA framework.
Bioelectric signalling through tissue β potential regulator of ECM integrity and cell polarity.
Neurotransmitters as systemic tissue modulators β serotonin, dopamine in ECM remodelling.
Stress hormones, cortisol, and sex hormones in modulating tissue microenvironment and differentiation.
Sympathetic/parasympathetic influence on tumour microenvironment β emerging clinical evidence.
Experience-dependent epigenetic modifications that may encode or unlock progenitor arrest states.
The RCA hypothesis generates a structured experimental program. Below are the thematic pillars, each with defined questions and testable predictions.
Core phenotypic characterisation β which cancer types show strongest progenitor signatures? Which regulatory checkpoints are disrupted?
What ECM components govern differentiation signalling? How does degradation create permissive conditions for progenitor arrest?
Organoid and in vivo models for testing differentiation restoration. APL as the proof-of-concept. What are the counterparts in solid tumours?
Infection β chronic inflammation β ECM degradation β progenitor arrest. Which pathogens? Which cancer types? What is the mechanistic chain?
Mathematical modelling of the dual regulatory architecture. When does the system lose stability? What restores it?
From experimental validation to regenerative oncology interventions. Differentiation therapy and ECM restoration as complementary approaches.
Published framework:
The RCA hypothesis is specific, falsifiable, and experimentally tractable. We are actively seeking partners to design and execute the decisive validation.